×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Head & Neck Cancer

Brielle Urciuoli
The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.
Brielle Urciuoli
After being diagnosed with a rare cancer, professional runner Gabriele Grunewald became inspired to start a nonprofit that raised awareness for other rare cancers and empowered those who have them.
Andrea Remke
I found my husband there in the dream. He was alive. He was healthy. He could talk again.
Kristie L. Kahl
After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.
Brielle Urciuoli
NFL Hall of Famer Jim Kelly confirmed his cancer has returned, according to recently issued statements from the Buffalo Bills.
 
Brielle Urciuoli
These findings bring light to a pressing problem in this patient population, and will hopefully pave the way for more awareness and potential change in practices.
Brielle Urciuoli
A variety of factors go in to the staging of a head and neck cancer diagnosis, however, the number of malignant lymph nodes may very well be the key to prognosis and treatment moving forward in this patient population.
 
Brielle Urciuoli
Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.
Andrea Remke
There are people out there who have never dealt with a devastating loss, yet apparently are experts when it comes to losing a spouse.
Joshua Bauml, M.D.
Joshua Bauml, M.D., assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the potential of therapeutic vaccine in patients who have head and neck cancer.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment

Caregiver

Healthcare Professional

Not Applicable